Physician
Preventive Medicine
Dr. Carlton K. Meschievitz, MD
|
|
Give Review
Carlton Meschievitz practices Preventive Medicine. He researched medicine at University of Wisconsin School of Medicine and Public Health. Carlton Meschievitz has written publications. He has 22 publications published with PubMed. The lastest publication is: 'Efficacy of a two-component acellular pertussis vaccine in infants.'
Publications
- Safety and immunogenicity of acellular diphtheria-tetanus-pertussis and Haemophilus conjugate vaccines given in combination or at separate injection sites.
- Interruption of transmission of rhinovirus colds among human volunteers using virucidal paper handkerchiefs.
- Prevention of experimental coronavirus colds with intranasal alpha-2b interferon.
- Short-duration exposure and the transmission of rhinoviral colds.
- A model for obtaining predictable natural transmission of rhinoviruses in human volunteers.
- Safety and immunogenicity of PRP-T combined with DTP: excretion of capsular polysaccharide and antibody response in the immediate post-vaccination period.
- Comparison of diphtheria-tetanus-two component acellular pertussis vaccines in United States and Japanese infants at 2, 4, and 6 months of age.
- Humoral and mucosal immunity in infants induced by three sequential inactivated poliovirus vaccine-live attenuated oral poliovirus vaccine immunization schedules. Balt...
- Efficacy of a two-component acellular pertussis vaccine in infants.
- Japanese encephalitis vaccine (inactivated, BIKEN) in U.S. soldiers: immunogenicity and safety of vaccine administered in two dosing regimens.
- Vaccine antigen interactions after a combination diphtheria-tetanus toxoid-acellular pertussis/purified capsular polysaccharide of Haemophilus influenzae type b-tetanu...
- Inactivated poliovirus vaccine alone or sequential inactivated and oral poliovirus vaccine in two-, four- and six-month-old infants with combination Haemophilus influe...
- Haemophilus influenzae type b polysaccharide-tetanus protein conjugate vaccine does not depress serologic responses to diphtheria, tetanus or pertussis antigens when c...
- Japanese encephalitis vaccine: persistence of antibody up to 3 years after a three-dose primary series.
- Safety and immunogenicity of an acellular pertussis vaccine booster in 15- to 20-month-old children previously immunized with acellular or whole-cell pertussis vaccine...
- Fifteen years of experience with Vero-produced enhanced potency inactivated poliovirus vaccine.
- Primary immunization series for infants: comparison of two-component acellular and standard whole-cell pertussis vaccines combined with diphtheria-tetanus toxoids.
- Choosing a route of administration for quadrivalent meningococcal polysaccharide vaccine: intramuscular versus subcutaneous.
- Randomized, controlled trial of recombinant human alpha-interferon in patients with chronic hepatitis B.
- A randomized controlled trial of a 12-month course of recombinant human interferon-alpha in chronic delta (type D) hepatitis: a multicenter Italian study.
- Comparison of 1 or 3 MU of interferon alfa-2b and placebo in patients with chronic non-A, non-B hepatitis.
Schools
University of Wisconsin Madison
Doctors Specialties
- Infectious Disease Medicine
- Preventive Medicine
Accepted Insurances
Education
-
University of Wisconsin School of Medicine and Public Health
Helpful Reviews
Similar Doctors
|
|
Dr. Maria C. Zepeda, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Humaira Shafi, MD |
|
|
Dr. Clare Helminiak, MD
This Doctor is OpenDoctor Recommended.
|